Åse Berg

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial

Unn Ljøstad, Eirik Skogvoll, Randi Eikeland et al. · The Lancet Neurology · 2008 · 271 citations

Medicine, Pharmacology, Pharmacotherapy +7

Evaluation of the Effects of Remdesivir and Hydroxychloroquine on Viral Clearance in COVID-19

Andreas Barratt‐Due, Inge Christoffer Olsen, Kateřina Nezvalová‐Henriksen et al. · Annals of Internal Medicine · 2021 · 123 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +15

Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations

Beate Vestad, Thor Ueland, Tøri Vigeland Lerum et al. · Journal of Internal Medicine · 2022 · 84 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

SARS-CoV-2–Specific Neutralizing Antibody Responses in Norwegian Health Care Workers After the First Wave of COVID-19 Pandemic: A Prospective Cohort Study

Mai-Chi Trieu, Amit Bansal, Anders Madsen et al. · The Journal of Infectious Diseases · 2020 · 48 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +13

Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial

Marius Trøseid, José Ramón Arribas, Lambert Assoumou et al. · Critical Care · 2023 · 47 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +10